No Prescription |
 |
 | ||
|
THALODA KEVADON |
|
| ||
No Prescription » Prescription Drugs 16 » THALODA KEVADON This medication is used to treat or prevent certain skin conditions related to Hansen's disease once known as leprosy (erythema nodosum leprosum). Thalidomide is also used with other drugs to treat a certain type of cancer (multiple myeloma). Thalidomide belongs to a class of drugs known as immunomodulators. It works in Hansen's disease by reducing swelling and redness (inflammation). It also reduces the formation of blood vessels that feed tumors.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat certain conditions caused by cancer HIV infection and other diseases (e.g. Crohn's disease).How to use Thalidomide OralRead the Patient Information Leaflet provided by your pharmacist before you start using thalidomide and each time you get a refill. Read and sign the informed consent provided by your doctor. If you have any questions consult your doctor or pharmacist.Take this medication by mouth with water usually once daily at bedtime at least 1 hour after the evening meal or as directed by your doctor.Dosage is based on your medical condition and response to treatment. Do not increase your dose or take this medication more often than prescribed. Your condition will not improve any faster and the risk of serious side effects may be increased.Keep the capsules in their blister pack until ready to use. If any of the powder from the capsule gets on your skin wash the area with soap and water.Since this drug can be absorbed through the skin and lungs women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from broken capsules. All people should wash their hands carefully after handling this drug.This medication passes into body fluids (e.g. urine). Avoid contact with body fluids from people taking this drug. Therefore wear protective clothing (e.g. gloves) when handling these body fluids (e.g. during cleanup). If contact occurs wash skin with soap and water.Use this medication regularly to get the most benefit from it. To help you remember take it at the same time each day. If you are taking this medication for Hansen's disease your skin condition may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased.Tell your doctor if your condition does not improve or if it worsens after 2 weeks.What conditions does this medication treat?Thalidomide Oral is used to treat the following:Acute Leprosy Reaction with Formation of Nodules Prevention of Acute Leprosy Reaction with Nodule Formation Multiple MyelomaThalidomide Oral may also be used to treat:Infection caused by Mycobacteria Significant Weight Loss from HIV A Chronic Multisystem Inflammatory Disorder Brain Tumor Porphyria Cutanea Tarda Repeatedly Occurring Small Ulcers of the Mouth Treatment to Prevent Recurrent Aphthous Stomatitis Crohn's Disease Pyoderma Gangrenosum Erythema Multiforme Disease that Causes Disc-Shaped Patches On the Upper Body Skin Disease in Patients with Discoid Lupus Erythematosus Swollen Itching Skin Lesions and Erosion of Skin Chronic Skin Disease causing Very Itchy Nodules Incompatibility Reaction Following Bone Marrow Transplant Treatment to Prevent Reaction After Bone Marrow Transplant Buy THALODA KEVADON and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About THALODA KEVADON: Product Type: Prescription Drugs 16 THALODA ( KEVADON GENERIC THALIDOMIDE ) THALODA (KEVADON GENERIC THALIDOMIDE) KEVADON GENERIC THALIDOMIDE 100MG KEVADON GENERIC THALIDOMIDE THALODA
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
